Remove 2022 Remove Competition Remove Specialization
article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Competition starts to heat up. Classic treatment options. About the author.

article thumbnail

It’s Time for Healthcare To Embrace Patient-Friendly Language

MedCity News

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. However, it’s a worthwhile endeavor not just for regulatory compliance but also for improving clinical outcomes and standing out in an increasingly competitive marketplace.

Patients 316
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

In 2022, the global clinical research market stands at $63.6 from 2022 to 2027. For that reason, it is also essential to be aware of the most prominent global research organizations that offer vital support with their specialized clinical trial solutions. billion with a CAGR of 11.0% So, let’s begin: 1.

article thumbnail

The Sales Pro’s Guide to Sales Prospecting

Integrity Solutions

Selling has become increasingly competitive. In addition to making the sales environment more challenging, these variables have made the competition to win new customers that much fiercer. Simply learning how to find, approach and engage new customers is at the heart of being able to meet and exceed your sales goals.

article thumbnail

You get what you agree to, at least when it comes to the money under VPAS

pharmaphorum

That is why companies who are members of the 2019 VPAS have collectively paid back almost £3 billion to the Department of Health and Social Care (DHSC) up to Quarter 2 of 2022. Source: DHSC (2022). The 15% rate for 2022 is lower than the maths automatically spits out. Source: DHSC (2018) and DHSC (2022).

article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

In the meantime the global competition to secure the production and supply of essential medicines is intensifying, and Europe needs to step up and face the challenge if it wants to stay in the race. Available at: [link] Teva Pharmaceuticals Europe ‘Addressing Europe’s Essential Medicines Exodus’ 2022.

Medicine 111